MOTION FOR A RESOLUTION
PDF 155kWORD 46k
3.1.2017
PE596.695v01-00
 
B8-1425/2016

pursuant to Rule 133 of the Rules of Procedure


on the HSV-1 and HSV-2 viruses


Mireille D'Ornano

Motion for a European Parliament resolution on the HSV-1 and HSV-2 viruses  
B8-1425/2016

The European Parliament,

–  having regard to Article 168 of the Treaty on the Functioning of the European Union,

–  having regard to Rule 133 of its Rules of Procedure,

A.  whereas the HSV-1 and HSV-2 viruses cause ulcers and whereas HSV-2 can lead to meningitis and fatal neonatal infections and triples the risk of contracting HIV;

B.  whereas 417 million people aged from 15-49 are infected with HSV-2; whereas it affects 18% of women and 13% of men in Western Europe; and whereas anti-viral drugs stop the virus spreading but do not eradicate it;

C.  whereas the phase II of the clinical trials of some preventative and therapeutic vaccines for HSV-2, such as GEN-003, are under way;

D.  whereas most Member States rarely carry out serological screening for HSV-1 and HSV-2, even though the viruses are contagious during the asymptomatic stage and PCR tests and antibodies do exist; 

1.  Urges the Commission and the Member States to link the fight against those viruses to HIV prevention programmes and to support research into vaccines;

2.  Urges the Commission and the Member States to make recommendations on screening with the assistance of the European Centre for Disease Prevention and Control.

Legal notice - Privacy policy